Glutathione-Depleting Gold Nanoclusters for Enhanced Cancer Radiotherapy through Synergistic External and Internal Regulations
The DOI matches its Crossref record.
Abstract
The therapeutic performance of cancer radiotherapy is often limited by the overexpression of glutathione (GSH) in tumors and low radiation sensitivity of cancerous cells. To address these issues, the facilely prepared histidine-capped gold nanoclusters (Au NCs@His) were adopted as a radiosensitizer with a high sensitization enhancement ratio of ∼1.54. On one hand, Au NCs@His can inherit the local radiation enhancement property of gold-based materials (external regulation); on the other hand, Au NCs@His can decrease the intracellular GSH level, thus preventing the generated reactive oxygen species (ROS) from being consumed by GSH, and arrest the cells at the radiosensitive G2/M phase (internal regulation).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Niu, B., Liao, K., Zhou, Y., Wen, T., Quan, G., Pan, X., & Wu, C. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121110 · Cited by 1,168
Engineering nanomedicine for glutathione depletion-augmented cancer therapy
Xiong, Y., Xiao, C., Li, Z., & Yang, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00718h · Cited by 692
Glutathione-Depleting Nanomedicines for Synergistic Cancer Therapy
Cheng, X., Xu, H.-D., Ran, H.-H., Liang, G., & Wu, F.-G. (2021) · ACS Nano · doi:10.1021/acsnano.1c00498 · Cited by 374
Self-citationSargazi, S., Fatima, I., Hassan Kiani, M., Mohammadzadeh, V., Arshad, R., Bilal, M., Rahdar, A., Díez-Pascual, A. M., & Behzadmehr, R. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.02.137 · Cited by 329
Nanozymes: Versatile Platforms for Cancer Diagnosis and Therapy
Zhang, X., Chen, X., & Zhao, Y. (2022) · Nano-Micro Letters · doi:10.1007/s40820-022-00828-2 · Cited by 304
Self-citationGlutathione-responsive and -exhausting metal nanomedicines for robust synergistic cancer therapy
Liu, P., Hao, L., Liu, M., & Hu, S. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1161472 · Cited by 58
“As a paradigm, Wu and co-workers integrated Au nanoclusters (Au NCs) with histidine to accomplish GSH exhaustive-prompted RT, denoted as Au NCs@His (Figure 7A) (Zhang et al., 2018).”
MethodSelf-citationBilynsky, C., Millot, N., & Papa, A. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10256 · Cited by 52
“5 | Radiosensitizer combination for an enhanced effect Radiosensitizer combinations have also been explored to achieve an enhanced therapeutic effect, including, but not limited to, tandems of: (i) two NP radiosensitizers,(125) (ii) NP radiosensitizers and a chemotherapeutic drug,(70) (iii) NP radiosensitizers and tum…”
BackgroundLiu, T.-I., Lu, T.-Y., Yang, Y.-C., Chang, S.-H., Chen, H.-H., Lu, I.-L., Sabu, A., & Chiu, H.-C. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120229 · Cited by 50
Samani, R. K., Tavakoli, M. B., Maghsoudinia, F., Motaghi, H., Hejazi, S. H., & Mehrgardi, M. A. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105487 · Cited by 40
Zhu, Z., Wu, M., Sun, J., Huangfu, Z., Yin, L., Yong, W., Sun, J., Wang, G., Meng, F., & Zhong, Z. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1995080 · Cited by 17
“2lM, which supports that high atom number element, like iodine, can act as a radiosensitizer by generating electrons (Sarbadhikary & Dube, 2017; Cheng et al., 2018; Zhang et al., 2018), and inducing the formation of a large number of free radicals, which can kill tumor cells (Xie et al.”
BackgroundAtkinson, J., Chopin, J., Bezak, E., Le, H., & Kempson, I. (2025) · ChemPhysChem · doi:10.1002/cphc.202400764 · Cited by 5
Metadata
- Authors
- Zhang, X., Chen, X., Jiang, Y.-W., Ma, N., Xia, L.-Y., Cheng, X., Jia, H.-R., Liu, P., Gu, N., Chen, Z., & Wu, F.-G.
- Venue
- ACS Applied Materials & Interfaces
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-03-15
- Volume
- 10
- Issue
- 13
- Pages
- 10601-10606
- ISSN
- 1944-8244 (ISSN-L)
- 1944-8252
- OpenAlex
- W2792926732
- Cited by
- 115
- References
- 0
- FWCI
- 8.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.